A randomized, double-blind comparison of botulinum toxin type A (Botox®) and divalproex sodium (Depakote®) for the prophylactic treatment of migraine headaches:: a pilot study

被引:0
|
作者
Porter, J [1 ]
机构
[1] Salem Neurol Ctr, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S490 / S491
页数:2
相关论文
共 50 条
  • [41] Low-dose botulinum toxin-A treatment of cervical dystonia - A double-blind, randomized pilot study
    Laubis-Herrmann, U
    Fries, K
    Topka, H
    EUROPEAN NEUROLOGY, 2002, 47 (04) : 214 - 221
  • [42] Botulinum toxin type-A in the prevention of migraine: A double-blind controlled trial
    Vo, Alexander H.
    Satori, Roberto
    Jabbari, Bahman
    Green, Jody
    Killgore, William D. S.
    Labutta, Robert
    Campbell, William W.
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2007, 78 (05): : B113 - B118
  • [43] Biological activity of two botulinum toxin type A complexes (Dysport® and Botox®) in volunteers A double-blind, randomized, dose-ranging study
    Wohlfarth, Kai
    Schwandt, Imke
    Wegner, Florian
    Juergens, Tim
    Gelbrich, Goetz
    Wagner, Armin
    Bogdahn, Ulrich
    Schulte-Mattler, Wilhelm
    JOURNAL OF NEUROLOGY, 2008, 255 (12) : 1932 - 1939
  • [44] A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox) and botulinum toxin, type B (Myobloc) on systemic and ocular autonomic symptoms and physiology in patients with cervical dystonia
    Tintner, R
    Gross, RL
    Winzer, UF
    Smalky, KA
    Jankovic, J
    MOVEMENT DISORDERS, 2004, 19 : S398 - S398
  • [45] Biological activity of two botulinum toxin type A complexes (Dysport® and Botox®) in volunteersA double-blind, randomized, dose-ranging study
    Kai Wohlfarth
    Imke Schwandt
    Florian Wegner
    Tim Jürgens
    Götz Gelbrich
    Armin Wagner
    Ulrich Bogdahn
    Wilhelm Schulte-Mattler
    Journal of Neurology, 2009, 256 : 1201 - 1201
  • [46] A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine
    Saper, Joel R.
    Mathew, Ninan T.
    Loder, Elizabeth W.
    DeGryse, Ronald
    VanDenburgh, Amanda M.
    PAIN MEDICINE, 2007, 8 (06) : 478 - 485
  • [47] Biological activity of two botulinum toxin type A complexes (Dysport® and Botox®) in volunteersA double-blind, randomized, dose-ranging study
    K. Wohlfarth
    I. Schwandt
    F. Wegner
    T. Jürgens
    G. Gelbrich
    A. Wagner
    U. Bogdahn
    W. Schulte-Mattler
    Journal of Neurology, 2008, 255 : 1932 - 1939
  • [48] Botulinum toxin as a preventive treatment for migraine:: a randomized double-blind placebo-controlled multi-centre study
    Petri, S
    Tölle, T
    Pfaffenrath, V
    Stefenelli, U
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S89 - S89
  • [49] RANDOMIZED DOUBLE-BLIND STUDY OF BOTULINUM TOXIN TYPE B FOR SIALORRHEA IN ALS PATIENTS
    Jackson, Carlayne E.
    Gronseth, Gary
    Rosenfeld, Jeffrey
    Barohn, Richard J.
    Dubinsky, Richard
    Simpson, C. Blake
    McVey, April
    Kittrell, Pamela P.
    King, Ruth
    Herbelin, Laura
    MUSCLE & NERVE, 2009, 39 (02) : 137 - 143
  • [50] Botulinum toxin type A compared with divalproex sodium for the prophylactic treatment of migraine: a 9-month randomised, evaluator-masked trial
    Blumenfeld, A.
    Schim, J.
    JOURNAL OF NEUROLOGY, 2006, 253 : 155 - 155